7VZM image
Entry Detail
PDB ID:
7VZM
Keywords:
Title:
Anti-CRISPR AcrIE4-F7
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2021-11-16
Release Date:
2022-02-09
Method Details:
Experimental Method:
Conformers Calculated:
1000
Conformers Submitted:
20
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:AcrIE4-F7
Chain IDs:A
Chain Length:120
Number of Molecules:1
Biological Source:Pseudomonas citronellolis
Ligand Molecules
Primary Citation
The structure of AcrIE4-F7 reveals a common strategy for dual CRISPR inhibition by targeting PAM recognition sites.
Nucleic Acids Res. 50 2363 2376 (2022)
PMID: 35166843 DOI: 10.1093/nar/gkac096

Abstact

Bacteria and archaea use the CRISPR-Cas system to fend off invasions of bacteriophages and foreign plasmids. In response, bacteriophages encode anti-CRISPR (Acr) proteins that potently inhibit host Cas proteins to suppress CRISPR-mediated immunity. AcrIE4-F7, which was isolated from Pseudomonas citronellolis, is a fused form of AcrIE4 and AcrIF7 that inhibits both type I-E and type I-F CRISPR-Cas systems. Here, we determined the structure of AcrIE4-F7 and identified its Cas target proteins. The N-terminal AcrIE4 domain adopts a novel α-helical fold that targets the PAM interaction site of the type I-E Cas8e subunit. The C-terminal AcrIF7 domain exhibits an αβ fold like native AcrIF7, which disables target DNA recognition by the PAM interaction site in the type I-F Cas8f subunit. The two Acr domains are connected by a flexible linker that allows prompt docking onto their cognate Cas8 targets. Conserved negative charges in each Acr domain are required for interaction with their Cas8 targets. Our results illustrate a common mechanism by which AcrIE4-F7 inhibits divergent CRISPR-Cas types.

Legend

Protein

Chemical

Disease

Primary Citation of related structures